Abstract
Delayed puberty is defined as the absence of any sign of puberty in a child at a chronological age two standard deviations above the mean age of pubertal development for a given population. By current standards, this is defined as absence of an increase in testicular volume (less than 4 mL) at 14 yr in a boy or absence of any breast development at 13 yr in a girl (1,2). In addition, pathologic abnormalities may be associated with abnormal progression through puberty once initial pubertal changes have begun, and are worthy of further evaluation. In boys, a period of 3.2 +/− 1.8 (mean +/− SD) years is necessary to achieve adult testicular volume after the onset of puberty. In girls, the period from breast budding to menarche is 2.4 +/−1.1 (mean +/− SD) years (3). Therefore, evaluation is warranted if more than 4−5 yr has elapsed from the onset of puberty to adult testicular size in boys or menarche in girls. Further evaluation is necessary to determine the etiology of pubertal delay, and for determination of necessary therapy. Clinical and laboratory assessment is aimed at differentiating a lag in normal pubertal development from abnormalities in need of further investigation and/or therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in girls. Am J Dis Child 1969; 44: 291–301.
Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Am J Dis Child 1970; 45: 13–21.
Argente J. Diagnosis of late puberty. Horm Res 1999;5 1 (Suppl 3 ): 95–100.
Warren PW. Effects of undernutrition on reproductive function in the human. Endocr Rev 1983; 4: 363–377.
Warren MP, Van de Wiele RL. Clinical and metabolic features of anorexia nervosa. Am J Ob Gyn 1973; 117: 435–449.
Weimann E, Witzel C, Schwidergall S, Bohles HJ. Perpubertal perturbations in elite gymnasts caused by sport specific training regimes and inadequate nutritional intake. Int J Sports Med 2000; 21 (3): 210–215.
Warren MP, Stiehl AL. Exercise and female adolescents: effects on the reproductive and skeletal systems. J Am Med Womens Assoc 1999; 54 (3): 115–120.
Crowley W Jr, Filicori M, Spratt D, Santoro N. The physiology of gonadotropin-releasing hormone (Gnrh) secretion in men and women. Recent Prog Horm Res 1985; 41: 473–531.
Weiss J, Crowley W Jr, Jameson JL. Normal structure of the gonadotropin-releasing hormone (Gnrh) gene is patients with GnRH deficiency and idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 1989; 69: 299–303.
Layman LC, Wilson JT, Huey LO, Lanclos KD, Plouffe L Jr, McDonough PG. Gonadotropin-releasing hormone, follicule-stimulating hormone beta, and luteinizing hormone beta gene structure in idiopathic hypogonadotropic hypogonadism. Fert Steril 1992; 57: 42–49.
Nakayama Y, Wondisford FE, Lash RW, et al. Analysis of gonadotropin-releasing hormone gene structure in families with familial central precocious puberty and idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 1990; 70: 1233–1238.
Weiss J, Adams E, Whitcomb RW, Crowley W Jr, Jameson JL. Normal sequence of the gonadotropinreleasing hormone gene in patients with idiopathic hypgonadotropic hypogonadism. Biol Reprod 1991; 45: 743–747.
Layman LC, Lanclos KD, Tho SPT, Sweet CR, McDonough PG. Patients with idiopathic hypogonadoptropic hypogonadism have normal gonadotropin-releasing hormone gene structure. Adolesc Pediatr Gynecol 1993; 6: 214–219.
Santen RJ, Paulsen CA. Hypogonadotropic eunuchoidism. I: clinical study of the mode of inheritance. J Clin Endocrinol Metab 1973; 36: 47–54.
Franco B, Guioli S, Pragliola A, et al. A gene deleted in Kallman’s syndrome shares homology with neural cell adhesion and axonal path-finding molecules. Nature 1991; 353: 529–536.
Legouis R, Hardelin J, Levilliers J, et al. The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules. Cell 1991; 67: 423–235.
Layman LC. The molecular basis of human hypogonadotropic hypogonadism. Mol Genet Metab 1999; 68: 191–199.
Georgopoulos NA, Pralong FP, Seidman CE, Seidman JG, Crowley W Jr., Vallejo M. Genetic heterogeneity evidenced by low incidence of KAL-1 gene mutations in sporadic cases of gonadotropinreleasing hormone deficiency. J Clin Endocrinol Metab 1997; 82: 213–217.
Zhang Y-H, Guo W, Wagner RL, et al. DAX1 mutations provide insight into structure-function relationships in steroidogenic tissue development. Am J Hum Genet 199862: 855–864.
Merke DP, Tajima T, Baron J, Cutler GB. Hypogonadotropic hypogonadism in a female caused by an X-linked recessive mutation in the DAX1 gene. N Engl J Med 340: 1248–1252.
de Roux N, Young J, Misrahi M, et al. A family with hypogonadotropic hypodonadism and mutations in the gonadotropin-releasing hormone receptor. N Engl J Med 1997; 337: 1597–1602.
Layman LC, Cohen DP, Jin M, et al. Mutations in the gonadotropin-releasing hormone receptor gene cause hypogonadotropic hypogonadism. Nat Genet 1998; 18: 14–15.
Weiss J, Axelrod L, Whitcomb RW, Harris PE, Crowley W Jr, Jameson JL. Hypogonadism caused by a single amino acid substitution in the ß subunit of luteinizing hormone. N Engl J Med 1992; 326: 179–183.
Matthews CH, Borgato S, Beck-Peccoz P, et al. Primary amenorrhea and infertility due to mutation in the ß-subunit of follicle-stimulating hormone. Nat Genet 1993; 5: 83–86.
Layman LC, Lee EJ, Peak DB, et al. Delayed puberty and hypogonadism caused by a mutation in the follicle stimulating hormone beta-subunit gene. N Engl J Med 1997; 337: 607–611.
Cogan JD, Wu W, Phillips JAI, et al. The PROP 1 2-base pair deletion is a commmon cause of combined pituitary hormone deficiency. J Clin Endocrinol Metab 1998; 83: 3346–3349.
Wu W. Cogan JD, Pfaffle RW, et al. Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nat Genet 1998; 18: 147–149.
Rappaport R, Brauner R. Growth and endocrine disorders secondary to cranial irradiation. Pediatr Res 1989; 25 (6): 561–567.
Smyth CM, Bremner WJ. Klinefelter syndrome. Arch Inter Med 1998; 158 (12): 1309–1314.
Laue L, Wu SM, Kudo M, et al. A nonsense mutation of the human luteinizing hormone receptor gene in Leydig cell hypoplasia. Hum Mol Genet 1995; 4: 1429–1433.
Kremer H, Kraaij R, Toledo SP, et al. Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene. Nat Genet 1995; 9: 160–164.
Latronico AC, Anasti J, Arnhold IJP, et al. Testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. N Engl J Med 1996; 334: 507–512.
Gromoll J, Eiholzer U, Nieschlag E, Simoni M. Male hypogonadism caused by homozygous deletion of exon 10 of the luteinizing hormone (LH) receptor: differential action of human chorionic gonadotropin and LH. J Clin Endocrinol Metab 2000; 85 (6): 2281–2286.
Jamieson CR, van der Burgt I, Brady AF, et al. Mapping a gene for Noonan syndrome to the long arm of chromosome 12. Nat Genet 1994; 8: 357–360.
Blagovidow N, Page DC, Huff DE, et al. Ullrich Turner syndrome in a XY female fetus with deletion of the sex-determining portion of the Y chromosome. Am J Med Genet 1989; 34: 159–162.
Scherer G, Chempp W, Baccichetti C, et al. Duplication of an Xp segment that includes the ZFX locus causes sex inversion in man. Hum Genet 1989; 81: 291–294.
Job J-C. Hypogonadism at Adolescence: Lack or Delay of Sexual Development? In: Fima Lifshitz, ed. Pediatric Endocrinology, 3rd Edition, Marcel Dekker, 1996.
Aittomaki K, Herva R, Stenman U-H, et al. Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene. J Clin Endo and Metab 1996; 81: 3722–3726.
Rappaport R, Maguelone GF. Disorders of sexual differentiation. In: Bertrand J, Rappaport R, Sizonenko P, Eds. Pediatric Endocrinology: Physiology, Pathophysiology, and Clinical Aspects, 2nd ed, Williams and Wilkins, 1993.
McPhaul MJ. Molecular defects of the androgen receptor. J Steroid Biochem Mol Biol 1999; 69 (1–6): 315–22.
Evans BAJ, Hughes IA, Bevan CL, Patterson MN, Gregory JW. Phenotypic diversity in siblings with partial androgen insensitivity syndrome. Arch Dis Child 1997; 76: 529–531.
Bramswig JH, Heimes U, Heiermann E, et al. The effects of different cumulative doses of chemotherapy on testicular function. Cancer 1990; 65: 1298–1302.
Chou RH, Wong GB, Kramer JH, et al. Toxicities of total-body irradiation for pediatric bone marrow transplantation. Int J Radiat Oncol Biol Phys 1996; 34 (4): 843–851.
Bayer L, Bayley N. Growth Diagnosis, University of Chicago Press, 1959.
Reynolds EL, Wines JV. Physical changes associated with adolescence in boys. Am J Dis Child 1951; 82: 529–547.
Odink RJ, Schoemaker J, Schoute E, Herder E, Delemarre-van de Waal HA. Predictive value of serum follicular-stimulating hormone levels in the differentiation between hypogonadotropic hypogonadism and constitutional delay of puberty. Horm Res 1998; 49 (6): 279–287.
Wu FCW, Brown DC, Butler GE, Stirling HF, Kelnar CJH. Early morning plasma testosterone is an accurate predictor of imminent pubertal development in prepubertal boys. J Clin Encrinol Metab 1990; 70: 26–31.
Gambineri A, Pasquali R. Testosterone therapy in men: clinical and pharmacological perspectives. J Endocrin Invest 2000; 23: 196–214.
Brook CGD. Treatment of late puberty. Horm Res 1999; 51 (Suppl 3): 101–103.
Tse W, Buyukgebiz A, Hindmarsh PC, Stanhope R, Preece MA, Brook CGD. Long-term outcome of oxandrolone treatment in boys with constitutional delay of growth and puberty. J Pediatr 1990; 117 (4): 588–591.
Wilson DM, McCauley E, Brown DR, Dudley R. Oxandrolone therapy in constitutionally delayed growth and puberty. Pediatrics 1995; 96 (6): 1095–1100.
Bourguignon J-P. Delayed puberty and hypogonadism. In: Bertrand J, Rappaport R, Sizonenko P, eds. Pediatric Endocrinology: Physiology, Pathophysiology, and Clinical Aspects, 2nd ed, Williams and Wilkins, 1993.
Bridges NA, Brook CDG. Disorders of puberty. In: Brook CGD, ed. Clinical Paediatric Endocrinology Blackwell Science, 1995.
Rose SR. Induction of puberty in female hypogonadism. The Endocrinologist 1996; 6 (6): 439–442.
Finkelstein JW, Susman EJ, Chinchilli VM, et al. Effects of estrogen or testosterone on self-reported sexual responses and behaviors in hypogonadal adolescents. J Clin Endocrinol Metab 1998; 83 (7): 2281–2285.
Susman EJ, Finkelstien JW, Chinchilli VM, et al. The effect of sex hormone replacement therapy on behavior problems and moods in adolescents with delayed puberty. J Pediatr 1998; 133 (4): 521–525.
Hoffman AR, Crowley WF. Induction of puberty in men by long-term pulsatile administration of low dose gonadotropin-releasing hormone. N Engl J Med 1982; 307: 1237–1241.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Stafford, D.E.J. (2003). Delayed Puberty. In: Radovick, S., MacGillivray, M.H. (eds) Pediatric Endocrinology. Contemporary Endocrinology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-336-1_22
Download citation
DOI: https://doi.org/10.1007/978-1-59259-336-1_22
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-268-1
Online ISBN: 978-1-59259-336-1
eBook Packages: Springer Book Archive